No to A-shares, says smart beta provider

Chinese_stock_quotesA major provider of smart beta investment tools says Chinese mainland-listed A-shares are not accessible enough to join its indices. Unlike index providers such as MSCI and FTSE Russell, which have said they will add A-shares to their emerging market indices, Scientific Beta, an initiative of the Edhec-Risk Institute, has concluded that accessibility constraints still “penalise” its global clients. In a statement, Scientific Beta said it was concerned by the need for derivative products based on A-shares to be pre-approved, by the large number of suspensions affecting A-shares as compared with other emerging markets, and by the daily limit on the Stock Connect scheme. Stock Connect is one of the main ways international investors can buy and sell A-shares. The index provider also noted that the market for securities lending and borrowing in China is limited. “The investment community has agreed that the Chinese equity market has undergone substantial changes in terms of accessibility to institutional investors, but Scientific Beta considers that increasing the number of Chinese stocks in an investment universe dedicated to smart beta is not appropriate at this time and could lead to investability issues for non-cap-weighted indices,” said the company. Instead of including A-shares in its indices, Scientific Beta has made Chinese ADRs (American Depositary Receipts) eligible for inclusion in its universe. ©2018 funds global asia

Executive Interviews

Interview: Money needs a place to go

Mar 11, 2019

Peng Fei, chief investment officer at Wanwei Asset Management, tells Romil Patel about allocating capital across risk factors when asset performance is uncertain and unpredictable.

INTERVIEW: Giving peace a chance

Jan 11, 2019

As US-China tensions escalated in 2018, the leaders of the two economies met in Buenos Aires to agree a truce. Aidan Yao, senior emerging Asia economist at Axa Investment Managers, talks to Romil...


Singapore roundtable: A money magnet

Mar 11, 2019

Our panel discussed why the Singapore Variable Capital Company makes them bullish, what gives the onshore jurisdiction an offshore feel and “blood on the streets” from China’s slowdown. Chaired by Romil Patel in Singapore.


Jan 11, 2019

Changes to regulation, US-Sino trade tensions and further steps by China to open its capital markets were some of the topics discussed by our panel. Chaired by Romil Patel in Hong Kong.